The Short Version
Published studies support that electrochemical enzyme-based biosensors can detect tumor-related metabolites such as glucose and lactate. Evidence includes cancer-cell and tumor-sample experiments using glucose- and lactate-oxidase sensors. The main caveat is that many demonstrations are proof-of-concept or ex vivo, so capability is established more clearly than routine clinical use.